Metrics as of 10/13/2026, 06:46 PM (Berlin time), refresh in progress.
Teleflex Stock
Teleflex Incorporated
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- United States
- CEO
- Jason Weidman
- Employees
- 15,500
- Market cap
- $5.5 B
- IPO
- 17/03/1980
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. Established in 1943, the company is headquartered in Wayne, Pennsylvania, and employs approximately 15,500 people. Teleflex serves a diverse customer base,…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Teleflex stock: price history
1D
+1.7%
1W
+4.2%
1M
+1.9%
6M
-0.9%
YTD
+6.9%
1Y
+5.3%
2Y
-44.5%
5Y
-64.1%
10Y
-22.2%
Next earnings date
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~107% stronger price swings than usual
Teleflex stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Ask the agents about Teleflex
Analyst assessment of Teleflex
PRICE TARGET LOW
US$140.00
CONSENSUS
US$155.25
MEDIAN
US$156.50
PRICE TARGET HIGH
US$170.00
0
STRONG BUY
16
BUY
13
HOLD
0
SELL
0
STRONG SELL
29
TOTAL · Buy
As of: 14/10/2026
Teleflex stock metrics
P/E
-5.38
P/B
1.88
EV/EBITDA
-51.21
RETURN ON EQUITY
3.5%
NET MARGIN
17.9%
DEBT/EQUITY
0.99
DIVIDEND YIELD
1.1%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.2%
FLOAT SHARES
43,907,936
AVG. DAILY VOLUME (30D)
800,655
Insider transactions (SEC)
Salmon Sean
RANDLE STUART A
RANDLE STUART A
RANDLE STUART A
Weidman Jason R.
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Teleflex stock
What does Teleflex do?
Teleflex Incorporated is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is Jason Weidman, the company employs around 15,500 people.
The IPO was on 17/03/1980; the stock trades on NYSE under the ticker TFX.
What do analysts say about Teleflex stock?
29 analysts rate the stock, the consensus is Buy (as of 14/10/2026).
The average price target is US$155.25, ranging from US$140.00 to US$170.00, with a median of US$156.50.
This is an external assessment, not a statement by Market Jury.
When does Teleflex report next?
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly 107% stronger than usual.
Does Teleflex pay a dividend?
Yes. The last dividend was US$0.34 per share, ex-date 14/08/2026, paid on 30/09/2026.
The dividend yield is 1.1% (as of 30/06/2026).
Which stocks are comparable to Teleflex?
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies and Avantor.
How can I get Teleflex stock analyzed?
Clicking "Analyze stock" lets five strategies assess Teleflex against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.